— Know what they know.
Not Investment Advice
Also trades as: CEVI.ST (STO) · $vol 1M

CLVSF OTC

CellaVision AB (publ)
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -17.6% 1Y: -27.4% 3Y: -14.1% 5Y: -57.5%
$14.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 48 · $333.9M mcap · 14M float · 0.0002% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$1.1B +8.1% ▲
5Y CAGR: +10.4%
Total Liabilities
$207M +5.7% ▲
5Y CAGR: -2.8%
Shareholders Equity
$888M +8.8% ▲
5Y CAGR: +15.6%
Cash & Investments
$188M +26.0% ▲
5Y CAGR: +13.0%
Total Debt
$26M -4.5% ▼
5Y CAGR: -28.0%
Net Debt
-$163M -32.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$130M$108M$122M$149M$188M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$130M$108M$122M$149M$188M
Net Receivables$115M$119M$112M$125M$141M
Inventory$115M$143M$126M$125M$112M
Other Current Assets$27M$25M$16M-$2M$0
Total Current Assets$365M$377M$366M$402M$441M
Property, Plant & Equip.$80M$110M$126M$120M$122M
Goodwill & Intangibles$358M$399M$223M$488M$529M
Long-Term Investments$22M$5M$0$3M$3M
Other Non-Current Assets$22M$5M$214M$0$6K
Total Non-Current Assets$460M$515M$563M$610M$654M
Total Assets$825M$892M$929M$1.0B$1.1B
— Liabilities —
Accounts Payable$45M$48M$33M$32M$36M
Short-Term Debt$41M$42M$36M$14M$14M
Deferred Revenue$45M$0$0$0$0
Other Current Liabilities$3M$8M$8M$62M$62M
Total Current Liabilities$134M$133M$119M$108M$111M
Long-Term Debt$96M$60M$29M$13M$12M
Other Non-Current Liab.$4M$4M$5M$6M$5M
Total Non-Current Liabilities$147M$117M$93M$88M$96M
Total Liabilities$282M$250M$212M$196M$207M
— Equity —
Common Stock$4M$4M$4M$4M$0
Retained Earnings$537M$608M$685M$772M$0
Accumulated OCI-$8M$19M$17M$30M$0
Total Stockholders Equity$543M$642M$716M$816M$888M
Total Liabilities & Equity$825M$892M$929M$1.0B$1.1B
— Key Metrics —
Total Debt$137M$102M$65M$27M$26M
Net Debt$6M-$6M-$57M-$123M-$163M
Total Investments$222K$188K$0$3M$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms